<DOC>
	<DOCNO>NCT02333851</DOCNO>
	<brief_summary>Pilot study compare efficacy safety premixed-insulin regimen ( 70 % intermediate insulin 30 % regular insulin ) basal-bolus insulin regimen ( glargine daily glulisine meal ) hospitalize patient type 2 diabetes .</brief_summary>
	<brief_title>Basal-bolus Premixed Insulin Regimens Hospitalized Patients With Type 2 Diabetes ( PININ Study )</brief_title>
	<detailed_description>Pilot , randomize , prospective , open-label study admit Hospital previous diagnosis type 2 diabetes blood glucose level admission great 180 mg/dl . Patients randomize receive premixed human insulin formulation 70 % intermediate insulin plus 30 % regular insulin ( Mixtard 30® , Novo Nordisk ) basal-bolus regimen glargine daily glulisine meal ( Lantus® Apidra® , Sanofi-Aventis ) . The primary outcome study determine difference glycemic control treatment group measure mean daily blood glucose concentration hospital stay . Secondary objective determine difference percentage glucose measure 80 180 mg/dl , frequency severity hypoglycemic event , total daily insulin use , length hospital stay glycemic viability group .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin glulisine</mesh_term>
	<mesh_term>Insulin , pork ; isophane insulin , pork drug combination 30:70</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<criteria>Previous diagnosis type 2 diabetes blood glucose level admission great 180 mg/dl treat diet , combination oral antidiabetic agent and/or insulin therapy Patients hyperglycemia without previous diagnosis diabetes Patients acute hyperglycemic emergency severe hyperglycemia treat intravenous insulin infusion admission Patients acute chronic kidney disease ( serum creatinine great 2 mg/dl ) , Patients treat corticosteroids Patients history severe repeat hypoglycemic episode Pregnant woman Patients expect require ICU admission le 3 day hospital stay</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Type 2 diabetes mellitus treatment</keyword>
	<keyword>Hospitalized patient</keyword>
</DOC>